Jeff Yass’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$249K Sell
18,300
-7,100
-28% -$93.5K ﹤0.01% 11412
2026
Q2
$240K Sell
25,400
-13,700
-35% -$131K ﹤0.01% 11567
2026
Q1
$357K Buy
+39,100
New +$328K ﹤0.01% 10482
2025
Q3
– Sell
-13,000
Closed -$86.1K – 12473
2025
Q2
$86.1K Sell
13,000
-20,600
-61% -$146K ﹤0.01% 11870
2025
Q1
$307K Sell
33,600
-17,900
-35% -$179K ﹤0.01% 10026
2024
Q4
$541K Sell
51,500
-31,500
-38% -$373K ﹤0.01% 8480
2024
Q3
$992K Sell
83,000
-17,100
-17% -$148K ﹤0.01% 6794
2024
Q2
$576K Buy
100,100
+1,500
+2% +$8.23K ﹤0.01% 7924
2024
Q1
$513K Buy
98,600
+31,500
+47% +$154K ﹤0.01% 8453
2023
Q4
$354K Sell
67,100
-8,300
-11% -$32.8K ﹤0.01% 9481
2023
Q3
$249K Buy
75,400
+57,100
+312% +$200K ﹤0.01% 9760
2023
Q2
$52.9K Buy
18,300
+3,300
+22% +$6.33K ﹤0.01% 11318
2023
Q1
$16K Buy
+15,000
New +$28.7K ﹤0.01% 12100

Other funds holding BVS

Jeff Yass's BVS Position: Q3 2026 in Review

Jeff Yass increased its Bioventus (BVS) stake by 62% in Q3 2026, buying an estimated $144K and bringing the position to 28,597 shares worth $390K. The position accounts for ﹤0.01% of the portfolio, ranked #10355.

Jeff Yass first reported a position in BVS in Q1 2021 and has held it in 14 quarters since. The position peaked at $1.51M in Q1 2024. 170 funds tracked by Wall St. Rank hold BVS as of Q3 2026.

  • Jeff Yass held 28,597 shares of Bioventus worth $390K as of Q3 2026.
  • Jeff Yass bought 10,905 Bioventus shares in Q3 2026, an estimated $144K.
  • Bioventus made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #10355 holding.
  • Jeff Yass first reported a position in Bioventus in Q1 2021 and has held it in 14 quarters since.
  • Jeff Yass's Bioventus position peaked at $1.51M in Q1 2024.
  • 170 funds tracked by Wall St. Rank held Bioventus as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.